Autism treatment is more than skin deep

Metal-binding agents rubbed into the skin, prescribed by some alternative practitioners for the treatment of autism, are not absorbed and therefore are unlikely to be effective at helping the body excrete excess mercury. The study by Jennifer Cohen and Michelle Ruha from Banner Good Samaritan Medical Center in the US, and their colleagues, provides evidence against the use of these treatments in children with autism. Their work is published online in Springer's Journal of Medical Toxicology.

Metal-binding agents such as DMPS* have received significant attention in recent decades amid the controversy over the link between mercury and . Even though no between mercury in vaccines and autism has been proven, some practitioners treat their patients with mercury-binding agents in an effort to help the body eliminate mercury and treat the autism. One of these agents is a formulation of DMPS which is applied to the skin, also known as . DMPS is approved in Europe for the treatment of heavy metal toxicity, but is not approved by the US FDA for use in the USA.

For the first time, Cohen and team looked at whether topically applied DMPS is absorbed into the body by measuring levels in the blood 30, 60, 90, 120, and 240 minutes after application. They also measured whether DMPS applied to the skin leads to increased of mercury in the urine 12 and 24 hours after application. The study comprised eight healthy adult volunteers and one control subject who ingested oral DMPS, which is proven to increase mercury excretion.

None of the collected from the healthy subjects contained detectable DMPS at any time point. DMPS was also not detected in 40 of 41 , with a single sample found to have a small amount of DMPS, considered by the authors to be contamination of the sample. The control subject given oral DMPS had increased levels of DMPS in the blood at every time point and also detectable DMPS in the urine. In addition, topical application of DMPS did not lead to increased mercury excretion, whereas oral intake led to a six-fold increase.

Michelle Ruha concludes: "This is the first study of an expensive, non-FDA approved medication that is advertised on the internet and used on children to treat autism. Our results show that the drug is not absorbed and does not work as a metal-binding agent, when applied to the skin."

More information: *2,3-Dimercaptopropane-1-sulfonate

Cohen JP, Ruha AM et al (2012). Plasma and urine dimercaptopropanesulfonate concerntrations after dermal application of transdermal DMPS (TD-DMPS). Journal of Medical Toxicology; DOI 10.1007/s13181-012-0272-9

add to favorites email to friend print save as pdf

Related Stories

Succimer found ineffective for removing mercury

Oct 22, 2010

Succimer, a drug used for treating lead poisoning, does not effectively remove mercury from the body, according to research supported by the National Institutes of Health. Some families have turned to succimer as an alternative ...

Recommended for you

Why do people with autism see faces differently?

9 hours ago

The way people with autism spectrum disorder (ASD) gather information - not the judgement process itself - might explain why they gain different perceptions from peoples' faces, according to a new study from ...

How does the brain develop in individuals with autism?

Nov 12, 2014

Geneticists at Heidelberg University Hospital's Department of Molecular Human Genetics have used a new mouse model to demonstrate the way a certain genetic mutation is linked to a type of autism in humans and affects brain ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

workingwithautism
not rated yet Nov 19, 2012
Very informative.
Working with Autism, located in Los Angeles, has helped hundreds of children with an Autism Spectrum Disorder to achieve their maximum potential for independence.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.